{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:14:26Z","timestamp":1788246866701,"version":"build-2803163510"},"reference-count":15,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"DOI":"10.1111\/bjh.70803","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:34:10Z","timestamp":1788244450000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed\/refractory del(17p) chronic lymphocytic leukaemia\/small lymphocytic lymphoma"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1813-9812","authenticated-orcid":false,"given":"Farrukh T.","family":"Awan","sequence":"first","affiliation":[{"name":"University of Texas Southwestern Medical Center  Dallas Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Liu","sequence":"additional","affiliation":[{"name":"AbbVie  North Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7160-5179","authenticated-orcid":false,"given":"Hsin\u2010Hui","family":"Huang","sequence":"additional","affiliation":[{"name":"AbbVie  North Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bye","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research (CIBMTR) Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4567-8037","authenticated-orcid":false,"given":"Kwang Woo","family":"Ahn","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research (CIBMTR) Medical College of Wisconsin  Milwaukee Wisconsin USA"},{"name":"Division of Biostatistics Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Krigsfeld","sequence":"additional","affiliation":[{"name":"AbbVie  North Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Raz","sequence":"additional","affiliation":[{"name":"AbbVie  North Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2076-6487","authenticated-orcid":false,"given":"Heather","family":"Wolfe","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center  Dallas Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5372-510X","authenticated-orcid":false,"given":"Mehdi","family":"Hamadani","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research (CIBMTR) Medical College of Wisconsin  Milwaukee Wisconsin USA"},{"name":"Division of Hematology & Oncology, Department of Medicine Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"issue":"3","key":"e_1_2_2_2_1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.6004\/jnccn.2024.0018","article-title":"Chronic lymphocytic leukemia\/small lymphocytic lymphoma, version 2.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Wierda WG","year":"2024","journal-title":"J Natl Compr Cancer Netw"},{"issue":"12","key":"e_1_2_2_3_1","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.bbmt.2016.09.013","article-title":"Clinical practice recommendations for use of allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia on behalf of the guidelines Committee of the American Society for blood and marrow transplantation","volume":"22","author":"Kharfan\u2010Dabaja MA","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"e_1_2_2_4_1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1182\/blood-2015-06-651125","article-title":"Long\u2010term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial","volume":"127","author":"Fischer K","year":"2016","journal-title":"Blood"},{"issue":"24","key":"e_1_2_2_5_1","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1200\/JCO.2008.21.1128","article-title":"Subcutaneous alemtuzumab in fludarabine\u2010refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German chronic lymphocytic leukemia study group","volume":"27","author":"Stilgenbauer S","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"e_1_2_2_6_1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/leu.2012.228","article-title":"Long\u2010term follow\u2010up of reduced\u2010intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome","volume":"27","author":"Brown JR","year":"2013","journal-title":"Leukemia"},{"issue":"12","key":"e_1_2_2_7_1","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1182\/blood-2017-04-775841","article-title":"Allogeneic hematopoietic cell transplantation for high\u2010risk CLL: 10\u2010year follow\u2010up of the GCLLSG CLL3X trial","volume":"130","author":"Kramer I","year":"2017","journal-title":"Blood"},{"issue":"17","key":"e_1_2_2_8_1","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1182\/blood-2017-10-810044","article-title":"Single\u2010agent ibrutinib in treatment\u2010naive and relapsed\/refractory chronic lymphocytic leukemia: a 5\u2010year experience","volume":"131","author":"O'Brien S","year":"2018","journal-title":"Blood"},{"issue":"3","key":"e_1_2_2_9_1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1400376","article-title":"Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia","volume":"371","author":"Byrd JC","year":"2014","journal-title":"N Engl J Med"},{"issue":"10","key":"e_1_2_2_10_1","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1470-2045(16)30212-1","article-title":"Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE\u201017): a phase 2, open\u2010label, multicentre study","volume":"17","author":"O'Brien S","year":"2016","journal-title":"Lancet Oncol"},{"issue":"19","key":"e_1_2_2_11_1","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood-2018-08-870238","article-title":"Long\u2010term follow\u2010up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab","volume":"133","author":"Byrd JC","year":"2019","journal-title":"Blood"},{"issue":"14","key":"e_1_2_2_12_1","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1182\/blood-2010-03-275420","article-title":"Allogeneic stem cell transplantation provides durable disease control in poor\u2010risk chronic lymphocytic leukemia: long\u2010term clinical and MRD results of the German CLL study group CLL3X trial","volume":"116","author":"Dreger P","year":"2010","journal-title":"Blood"},{"issue":"4","key":"e_1_2_2_13_1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/bjh.15421","article-title":"Evaluation of 230 patients with relapsed\/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials","volume":"182","author":"Jones J","year":"2018","journal-title":"Br J Haematol"},{"issue":"4","key":"e_1_2_2_14_1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E\u2010value","volume":"167","author":"VanderWeele TJ","year":"2017","journal-title":"Ann Intern Med"},{"issue":"17","key":"e_1_2_2_15_1","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1182\/bloodadvances.2020002184","article-title":"Allogeneic hematopoietic cell transplantation after prior targeted therapy for high\u2010risk chronic lymphocytic leukemia","volume":"4","author":"Kim HT","year":"2020","journal-title":"Blood Adv"},{"issue":"16","key":"e_1_2_2_16_1","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1182\/bloodadvances.2020001956","article-title":"Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents","volume":"4","author":"Roeker LE","year":"2020","journal-title":"Blood Adv"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.70803","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.70803","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.70803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:34:13Z","timestamp":1788244453000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.70803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":15,"alternative-id":["10.1111\/bjh.70803"],"URL":"https:\/\/doi.org\/10.1111\/bjh.70803","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"2026-02-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"bjh.70803"}}